EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte StudieMultizentrische StudieÄquivalenzstudieOpen access · CC BY-NC 4.0

Labor induction at 41 +0 gestational weeks or expectant management for the nulliparous woman: The Finnish randomized controlled multicenter trial

Katariina Place iD, Leena Rahkonen iD, Aydin Tekay, Kirsi Väyrynen, Maija-Riitta Orden, Marja Vääräsmäki, Jukka Uotila, Kati Tihtonen iD, Kirsi Rinne, Kaarin Mäkikallio, Seppo Heinonen, Heidi Kruit iD

Acta Obstetricia et Gynecologica Scandinavica · 2024

DOI: 10.1111/aogs.14755 ↗

At a glance

Randomisierte kontrollierte Studie in Acta Obstetricia et Gynecologica Scandinavica, 2024. Written by Katariina Place and 11 co-authors. Institution: Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. Major MEDLINE topics: Cesarean Section, Watchful Waiting. Cited 4 times so far (Crossref); 24 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Introduction

Neonatal and maternal risks increase in term pregnancy as gestational age advances and become increasingly evident post‐term. Management practices of late‐ and post‐term pregnancies vary, and the optimal time point for intervention by labor induction is yet to be determined. Material and methods This randomized controlled trial of 381 nulliparous women with unripe cervices compared labor induction at 41 +0 gestational weeks (early induction) with expectant management and labor induction at 41 +5 to 42 +1 gestational weeks (expectant management). This multicenter study included all five university hospitals and the largest central hospital in Finland. The study period was 2018–2022. Participants were randomized to either early induction (48.8%, n = 186) or expectant management (51.2%, n = 195) with equal randomization ratios of 1:1. This was a superiority trial, and the primary outcomes were rates of cesarean section (CS) and composite of adverse neonatal outcomes. The trial was registered at the ISRCTN registry (ISRCTN83219789, https://doi.org/10.1186/ISRCTN83219789 ).

Results

The rates of CS (16.7% [ n = 31] vs. 24.1% [ n = 47], RR 0.7 [95% CI: 0.5–1.0], p = 0.07) and a composite of adverse neonatal outcomes (9.7% [ n = 18] vs. 14.4% [ n = 28], RR 0.7 [95% CI: 0.4–1.2] p = 0.16) did not significantly differ between the groups, but the operative delivery rate was lower in the early induction group than in the expectant management group (30.6% [ n = 57] vs. 45.6% [ n = 89], p = 0.003). The rates of hemorrhage ≥1000 mL and neonatal weight ≥4000 g were also lower in the early induction group, as was the vacuum extraction rate in women with vaginal delivery. Of the women with expectant management, 45.6% ( n = 89) had spontaneous onset of labor. No perinatal deaths occurred, but one case of eclampsia appeared in the expectant management group.

Conclusions

Offering labor induction to nulliparous women at 41 +0 gestational weeks may decrease the probability of operative delivery, postpartum hemorrhage, and neonatal weight ≥4000 g. However, this study was underpowered to affirm the trends of rising rates of CS and adverse neonatal outcomes in the expectant management group. Thus, expectant management could remain an option for some, as one in two women with expectant management had a spontaneous onset of labor.

Subjects

MeSH terms (MEDLINE)

Cesarean SectionWatchful WaitingInfant, NewbornPregnancyFemaleHumansFinlandDelivery, ObstetricLabor, InducedGestational Age

Author keywords

expectant managementlabor inductionlate-term pregnancypost-term pregnancyprolonged pregnancy

Authors and institutions

  • Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Department of Obstetrics and Gynecology, Central Finland Central Hospital, Jyväskylä, Finland.
  • Department of Obstetrics and Gynecology, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland.
  • Clinical Medicine Research Unit, Department of Obstetrics and Gynecology, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Department of Obstetrics and Gynecology, Tampere University Hospital and Tampere University, Tampere, Finland.
  • Department of Obstetrics and Gynecology, Turku University Hospital and University of Turku, Turku, Finland.

ORCID profiles: Katariina Place, Leena Rahkonen, Kati Tihtonen, Heidi Kruit

Cite

APA

Place, K., Rahkonen, L., Tekay, A., Väyrynen, K., Orden, M. R., Vääräsmäki, M., Uotila, J., Tihtonen, K., Rinne, K., Mäkikallio, K., Heinonen, S., & Kruit, H. (2024). Labor induction at 41 +0 gestational weeks or expectant management for the nulliparous woman: The Finnish randomized controlled multicenter trial. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14755

Vancouver

Place K, Rahkonen L, Tekay A, Väyrynen K, Orden MR, Vääräsmäki M, et al. Labor induction at 41 +0 gestational weeks or expectant management for the nulliparous woman: The Finnish randomized controlled multicenter trial. Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14755

BibTeX
@article{Place2024,
  author = {Place, Katariina and Rahkonen, Leena and Tekay, Aydin and Väyrynen, Kirsi and Orden, Maija-Riitta and Vääräsmäki, Marja and Uotila, Jukka and Tihtonen, Kati and Rinne, Kirsi and Mäkikallio, Kaarin and Heinonen, Seppo and Kruit, Heidi},
  title = {Labor induction at 41 +0 gestational weeks or expectant management for the nulliparous woman: The Finnish randomized controlled multicenter trial},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2024},
  doi = {10.1111/aogs.14755}
}
Start for free →